Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis
Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis is a paper indexed in PICO Portal from OpenAlex.
How many citations does Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis have?
Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis has 30 citations in the OpenAlex counts PICO Portal stores.
When was Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis published?
Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis has 2017 year in the PICO Portal index.
What is the open-access status of Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis?
Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis has gold oa status in the PICO Portal index.
What is the DOI of Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis?
The DOI for Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis is on the source record.
What is the PMID of Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis?
The PMID for Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis is on the source record.
What is the OpenAlex record for Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis?
The OpenAlex for Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis is on the source record.